ArticleLung India : official organ of Indian Chest Society2026
Normal spirometry with high and asthma-defining bronchodilator responsiveness: An appraisal from real-life data.
Article in Lung India : official organ of Indian Chest Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpirometric exercise in symptomatic patients (with/without suspicion of airflow obstruction) often ends with results showing normal pre-bronchodilator values.
methodsWe screened two different populations with prospectively archived spirometry, consisting of a) clinical suspicion of OAD (obstructive airway disease) and b) all other indications without any suspicion of OAD. Both populations underwent BDR (bronchodilator responsiveness) with salbutamol. We screened out the patients that displayed 'normal spirometry' [pre-bronchodilator (FEV1/FVC > 0.7 with FEV1 and FVC > 80%] and further looked for the presence of high (≥200 mL alone) or asthma-defining (>200 mL and 12%) BDR in them.
resultsThe two sets included 1019 and 3060 subjects in patients with or without suspected OAD. They showed the presence of 11.87% (121/1019) and 27.71% (848/3060) of normal spirometry. In the first set, 24.7% ( n = 30) and 17.35% ( n = 21), and in the second set, 12.26% ( n = 104) and 4.7% ( n = 40) patients had high (>200 mL) or asthma-defining (200 mL plus 12%) BDR. Thus, the asthma-defining BDR is present in 2.06% (21/1019) and 1.30% (40/3060) of patients with or without suspected OAD with normal pre-bronchodilator spirometry. The prevalence of isolated high BDR (200 mL) was present in 0.88% [9 (30-21) out of 1019] and 2.09% [ n = 64 (135-54)/3060] of them.
conclusionSome patients with respiratory symptoms with or without suspicion of airflow obstruction display pre-bronchodilator normal spirometry, and some of them demonstrate high or asthma-defining bronchodilator responsiveness. Performing BDR should be a routine in respiratory practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.